Study reveals why some depressed patients have blood inflammation

May 5, 2016, King's College London
Study reveals why some depressed patients have blood inflammation

A new King's College London study reveals why some - but not all - people have depression that appears to be caused by blood inflammation.

These insights could help researchers to develop novel treatment strategies for the many depressed who do not get better using current antidepressants.

Recent research suggests that patients with depression have measurable changes in the blood that indicate activation of the inflammatory system - a biological response which is predominantly directed to fight infection but which also has an important role in regulating mood and behaviour.

Blood is known to worsen in the brain, which occurs when the body both overproduces and then struggles to remove molecules called 'free radicals.' These free radicals break down brain connections and disrupt the brain's chemical signalling, which in turn can lead to the development of by reducing the brain's protective mechanisms.

This new King's research, published in Neuropsychopharmacology, indicates that some depressed patients are predisposed to develop depression when their inflammatory system is activated because they are more 'biologically sensitive' to inflammation. As a result, their brains are more likely to suffer.

Researchers have known for many years that approximately one third of patients who take an anti-viral immune drug called 'interferon-alpha' develop depression, because this drug activates the inflammatory system. The King's College London research team set out to study patients taking interferon-alpha as a model for inflammation-induced depression, in order to dissect the mechanisms through which an activated inflammatory system causes depressive symptoms in some but not all individuals.

They measured the activation of multiple biological systems in the blood of 58 patients before and after the inflammatory activation with interferon-alpha, and correlated changes in these systems with the onset of depressive symptoms.

The researchers found that patients who developed depressive symptoms following the inflammatory activation tended to be more biologically sensitive to interferon-alpha. Specifically, they had a more reactive inflammatory system, and also showed more changes in biological systems involved in oxidative stress and in the protection of brain cells.

Dr Nilay Hepgul, lead author of the study from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London, said: 'Our results are important not only for understanding the high prevalence of depression amongst individuals receiving interferon-alpha treatment, but also to identify those at risk of developing in the context of high inflammation due to other causes, such as severe stress or medical illnesses.'

Professor Carmine Pariante, senior author of the study from the IoPPN at King's College London, said: 'Both oxidative stress and brain protective mechanisms can be considered future targets for the development of novel, effective antidepressant strategies, especially for patients with high levels of inflammation who do not get better using current antidepressants.'

Professor Pariante added: 'Our next aim is to understand the implications of this increased inflammation in the blood and whether it has direct consequences for the brain, using neuroimaging techniques.

'We also need to understand why some patients are more biologically sensitive to increased inflammation. Do they have a specific genetic profile that makes them more susceptible, or has exposure to stress life events had an impact - or both?'

Explore further: Inflammation attacks brain's reward center

More information: Nilay Hepgul et al. Transcriptomics in Interferon-α-Treated Patients Identifies Inflammation-, Neuroplasticity- and Oxidative Stress-Related Signatures as Predictors and Correlates of Depression, Neuropsychopharmacology (2016). DOI: 10.1038/npp.2016.50

Related Stories

Inflammation attacks brain's reward center

February 2, 2016
A new study by Neil Harrison and colleagues published in Biological Psychiatry suggests that a brain reward center, the striatum, may be directly affected by inflammation and that striatal change is related to the emergence ...

Omega-3 fatty acids may prevent some forms of depression

October 1, 2014
Patients with increased inflammation, including those receiving cytokines for medical treatment, have a greatly increased risk of depression. For example, a 6-month treatment course of interferon-alpha therapy for chronic ...

Uncovering the source of inflammatory malaise

October 22, 2012
(Medical Xpress)—A study conducted by researchers at Emory indicates that inflammation targets a part of the brain called the basal ganglia, causing symptoms of depression and fatigue. The study was recently reported in ...

Inflammation markers could guide depression treatments

January 12, 2016
Psychiatrists investigating depression have been energized in recent years by reports of rapid, successful treatment with drugs that interfere with the brain chemical glutamate, such as the anesthetic ketamine.

Inflammatory pathways could be key to resolving heart disease and depression link

March 24, 2016
Heart health scientists are working to establish therapies to combat the physical link between cardiovascular disease and depression.

New biological evidence reveals link between brain inflammation and major depression

January 28, 2015
A new study by the Centre for Addiction and Mental Health (CAMH) found that the measure of brain inflammation in people who were experiencing clinical depression was increased by 30 per cent. The findings, published today ...

Recommended for you

People are more honest when using a foreign tongue, research finds

August 17, 2018
New UChicago-led research suggests that someone who speaks in a foreign language is probably more credible than the average native speaker.

FDA approves brain stimulation device for OCD

August 17, 2018
(HealthDay)—A brain stimulation device to treat obsessive-compulsive disorder (OCD) has received approval for marketing Friday by the U.S. Food and Drug Administration.

Research eyes role of stress in mental illnesses

August 17, 2018
We all face stress in our lives. Even researchers seeking to understand why some people shrug it off while others face battles against disorders like depression or PTSD.

16 going on 66: Will you be the same person 50 years from now?

August 17, 2018
How much do you change between high school and retirement? The answer depends on whether you're comparing yourself to others or to your younger self.

Expecting to learn: Language acquisition in toddlers improved by predictable situations

August 16, 2018
The first few years of a child's life are crucial for learning language, and though scientists know the "when," the "how" is still up for debate. The sheer number of words a child hears is important; that number predicts ...

Letting PTSD patients choose method of treatment improves their health, quality of life: new research

August 16, 2018
Letting people with post-traumatic stress disorder (PTSD) choose between treatment methods improves their quality of life and reduces the disorder's symptoms, according to new research from Case Western Reserve University.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.